VANGUARD GROUP INC - CYTEK BIOSCIENCES INC ownership

CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 53 filers reported holding CYTEK BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CYTEK BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$61,158,404
-32.6%
11,079,421
+4.3%
0.00%0.0%
Q2 2023$90,680,101
+25.1%
10,618,279
+34.7%
0.00%0.0%
Q1 2023$72,467,635
-8.7%
7,885,488
+1.5%
0.00%0.0%
Q4 2022$79,342,595
-29.9%
7,771,067
+1.1%
0.00%
-33.3%
Q3 2022$113,161,000
+68.1%
7,687,505
+22.5%
0.00%
+50.0%
Q2 2022$67,317,000
-1.7%
6,273,802
-1.2%
0.00%0.0%
Q1 2022$68,475,000
+246.3%
6,352,090
+424.2%
0.00%
Q4 2021$19,776,000
-22.8%
1,211,746
+1.3%
0.00%
-100.0%
Q3 2021$25,615,0001,196,3720.00%
Other shareholders
CYTEK BIOSCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,300,000$13,273,0008.92%
Miura Global Management 780,000$7,963,8004.01%
RA Capital Management 13,381,054$136,620,5612.77%
HHLR ADVISORS, LTD. 8,684,530$88,669,0511.87%
Brown Capital Management 5,107,878$52,151,4340.86%
Perceptive Advisors 1,289,534$13,166,1420.37%
Hillsdale Investment Management Inc. 344,529$3,517,6410.30%
PURA VIDA INVESTMENTS, LLC 420,749$4,295,8470.22%
FOX RUN MANAGEMENT, L.L.C. 19,881$202,9850.08%
INNOVIS ASSET MANAGEMENT LLC 14,565$148,7090.07%
View complete list of CYTEK BIOSCIENCES INC shareholders